PPIDT00093
Drug Information
| Name | Bleomycin |
|---|---|
| Sequence | Not Available |
| DrugBank_ID | DB00290 |
| Type | small molecule |
| Indication | For palliative treatment in the management malignant neoplasm (trachea, bronchus, lung), squamous cell carcinoma, and lymphomas. |
Dosage Forms
| Form | Route | Strength |
|---|---|---|
| Injection | Intramuscular; Intrapleural; Intravenous; Subcutaneous |
|
| Injection, powder, lyophilized, for solution | — |
15 mg
|
| Injection, powder, lyophilized, for solution | — |
|
| Injection, powder, for solution | Intramuscular; Intrapleural; Intravenous; Subcutaneous |
15 [USP'U]/1
|
| Injection, powder, for solution | Intramuscular; Intrapleural; Intravenous; Subcutaneous |
30 [USP'U]/1
|
| Powder, for solution | Intramuscular; Intravenous |
15 unit / amp
|
| Injection, powder, for solution | — |
15 mg
|
| Injection, solution | Intramuscular; Intrapleural; Intravenous; Subcutaneous |
15 mg
|
| Solution | Parenteral |
15 U
|
| Solution | Parenteral |
15 UI
|
| Injection, powder, for solution | — |
|
| Powder | Intravenous |
1500000 IU
|
| Injection, powder, lyophilized, for solution | Parenteral |
1500000 IU
|
| Injection, powder, lyophilized, for solution | Intramuscular; Intravenous |
1500000 U
|
| Injection | Intramuscular; Intrapleural; Intravenous; Subcutaneous |
15 [USP'U]/1
|
| Injection, powder, lyophilized, for solution | Intra-arterial; Intramuscular; Intravenous |
15000 [iU]/1
|
| Injection, powder, lyophilized, for solution | Intramuscular; Intrapleural; Intravenous; Subcutaneous |
15 [USP'U]/1
|
| Injection, powder, lyophilized, for solution | Intramuscular; Intrapleural; Intravenous; Subcutaneous |
30 [USP'U]/1
|
| Powder, for solution | Intramuscular; Intrapleural; Intravenous; Subcutaneous |
15 [USP'U]/1
|
| Powder, for solution | Intramuscular; Intrapleural; Intravenous; Subcutaneous |
30 [USP'U]/1
|
| Injection, powder, for solution | Parenteral |
15000 IU/mg
|
| Injection, powder, for solution | Parenteral |
15000 IE
|
| Powder, for solution | Intra-arterial; Intracavitary; Intramuscular; Intravenous; Subcutaneous |
15 unit / vial
|
| Powder, for solution | Intramuscular; Intrapleural; Intravenous; Subcutaneous |
15 unit / vial
|
| Injection, powder, for solution | Parenteral |
15 MG
|
| Injection, powder, lyophilized, for solution | Intramuscular; Intravenous; Subcutaneous |
1500000 IU
|
| Injection, powder, for solution | — |
15 unit/1vial
|
| Solution | Parenteral |
15.000 UI
|
| Injection, powder, lyophilized, for solution | Intramuscular; Intravenous |
1500000 IU
|
| Injection, powder, for solution | Intramuscular; Intravenous; Subcutaneous |
15000 iu/vial
|
| Injection | Intramuscular; Intrapleural; Intravenous; Subcutaneous |
1 U/ml
|
| Solution | Intravenous |
9.900 mg
|
| Powder | Intravenous |
15 unit/1vial
|